Oxford Drug Company,Limited - Dormant accounts - members and to registrar (filleted) 20.1

REGISTERED NUMBER: 00031789 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 27 JANUARY 2019 TO 1 FEBRUARY 2020

FOR

OXFORD DRUG COMPANY,LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

Chartered Accountants' Report

4

DIRECTORS:

J A H Pearson

S B Pearson

J S Moyle

J H R Waite

SECRETARY:

S B Pearson

REGISTERED OFFICE:

Boswell House

1-4 Broad Street

Oxford

Oxfordshire

OX1 3AG

REGISTERED NUMBER:

00031789 (England and Wales)

ACCOUNTANTS:

THP Limited

Chartered Accountants

34-40 High Street

Wanstead

London

E11 2RJ

CURRENT ASSETS

Debtors

4

2,750

TOTAL ASSETS LESS CURRENT
LIABILITIES

2,750

CAPITAL AND RESERVES

Called up share capital

2,000

Share premium

750

SHAREHOLDERS' FUNDS

2,750

The company is entitled to exemption from audit under Section 480 of the Companies Act 2006 for the period ended 1 February 2020.

The members have not required the company to obtain an audit of its financial statements for the period ended 1 February 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the
end of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 June 2020 and were
signed on its behalf by:

J S Moyle - Director

1.	STATUTORY INFORMATION

Oxford Drug Company,Limited is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2019 - NIL).

4.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2020

2019

£

Amounts owed by parent company

2,750

The following reproduces the text of the report prepared for the directors in respect of the company's

annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only

required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other

primary statements and the Report of the Directors are not required to be filed with the Registrar of

Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements of Oxford Drug Company,Limited for the period ended 1 February 2020 which comprise the

Income Statement, Balance Sheet and the related notes from the company's accounting records and from information

and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Oxford Drug Company,Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Oxford Drug Company,Limited and state those matters that we have agreed to state to the Board of Directors of Oxford Drug Company,Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Oxford Drug Company,Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Oxford Drug Company,Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Oxford Drug Company,Limited. You consider that Oxford Drug Company,Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Oxford Drug Company,Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

THP Limited

Chartered Accountants

34-40 High Street

Wanstead

London

E11 2RJ

15 June 2020